2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Late Breaking I

96.3 - Hypothermic Ex Vivo Perfusion Prevents Ischemia Reperfusion Injury in Rat Lungs from Non-Heart-Beating Donors

Presenter: Daisuke, Nakajima, Kyoto, Japan
Authors: Nakajima D., Yamada T., Chen F., Sakamoto J., Kojima F., Ohsumi A., Fujinaga T., Shoji T., Sakai H., Bando T., Date H.

HYPOTHERMIC EX VIVO PERFUSION PREVENTS ISCHEMIA REPERFUSION INJURY IN RAT LUNGS FROM NON-HEART-BEATING DONORS

LATE BREAKING I

D. Nakajima, T. Yamada, F. Chen, J. Sakamoto, F. Kojima, A. Ohsumi, T. Fujinaga, T. Shoji, H. Sakai, T. Bando, H. Date
Thoracic Surgery, Kyoto University, Kyoto/JAPAN

Body: Introduction. To resolve the shortage of donor lungs, the use of non-heart-beating donors (NHBD) has come into practice. An ideal method of preservation that can improve the quality of NHBD lungs has been investigated. Hypothermic machine perfusion has been widely used to preserve kidneys for transplantation with better results than static cold storage. Therefore, we investigated whether hypothermic ex vivo perfusion can improve the quality of NHBD lungs. Methods. Male Lewis rats were used. Ninety minutes after cardiac arrest induced by ventricular fiblliration, hypothermic ex vivo lung perfusion (HEVLP) was performed using Low Potassium Dextran solution with serum albumin for 60 minutes at 6-10 ℃. The first study investigated the physiological lung function during HEVLP and the lung tissue energy levels before and after HEVLP. In the second study, the rats were allocated into 3 groups (n=6 each): no ischemia (Group I); 90 minutes warm ischemia + 60 minutes HEVLP + 120 minutes static cold storage (Group II); 90 minutes warm ischemia + 180 minutes static cold storage (Group III). In all groupes, lungs were reperfused for 60 minutes at 37 ℃ by an isolated rat lung perfusion model, in which lung functions were evaluated on time during reperfusion. Results. Lung functions (pulmonary compliance, airway resistance, mean pulmonary artery pressure, lung weight) were stable during HEVLP. Lung tissue energy levels decreased during warm ischemia (TAN 4.31, ATP 1.03, ADP 0.81 nmol/mg), but significantly increased by HEVLP (TAN 5.93, ATP 2.64, ADP 1.12 nmol/mg, p<0.05). During reperfusion, HEVLP significantly decreased airway resistance, shunt fraction and pulmonary vascular resistance. HEVLP also significantly increased pulmonary compliance and oxygenation. Conclusions. Short-term hypothermic ex vivo lung perfusion improved lung tissue energy levels which decreased during warm ischemia, and prevented ischemia reperfusion injury.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada